CHRONOSCLOUD, INC. – Trademark Portfolio
Entity Type: 03
CHRONOSCLOUD, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CHRONOSCLOUD and CHRONOSTOUCH. The owner is based in DANVILLE, CA.
4185 BLACKHAWK PLAZA CIRCLE, SUITE 260
DANVILLE, CA 94506
Showing of trademarks Trademarks
Trademark Classifications
CHRONOSCLOUD, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does CHRONOSCLOUD, INC. have?
CHRONOSCLOUD, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned, 1 cancelled.
What trademark classes does CHRONOSCLOUD, INC. file in?
CHRONOSCLOUD, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are CHRONOSCLOUD, INC.'s most well-known trademarks?
CHRONOSCLOUD, INC.'s registered trademark portfolio includes well-known marks such as CHRONOSCLOUD and CHRONOSTOUCH. These are among 2 currently registered trademarks in the portfolio.
What is CHRONOSCLOUD, INC.'s trademark registration success rate?
CHRONOSCLOUD, INC. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.